COMPANY
Carolina Infusion
Carolina Infusion: recalling firm for Semaglutide, Sermorelin, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Semaglutide | Class II recall, Completed, 2022-09-21 Regulator openFDA |
|---|---|
| Sermorelin | Class II recall, Completed, 2022-09-21 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.